Web-Based Module for the Collection of Electronic Patient-Reported Outcomes in People Living With HIV in Nouvelle Aquitaine, France: Usability Evaluation.

patient generated health data patient reported outcome measures quality of life

Journal

JMIR formative research
ISSN: 2561-326X
Titre abrégé: JMIR Form Res
Pays: Canada
ID NLM: 101726394

Informations de publication

Date de publication:
18 Dec 2019
Historique:
received: 12 06 2019
accepted: 07 09 2019
revised: 07 08 2019
entrez: 19 12 2019
pubmed: 19 12 2019
medline: 19 12 2019
Statut: epublish

Résumé

Patient-reported outcomes (PROs) can be of great value for both research and chronic disease management. We developed a new module of the ANRS CO3 Aquitaine cohort study's Web-based data capture and visualization solution (APPEGE 2.0) for the collection of electronic PROs among people living with HIV cared for in Nouvelle Aquitaine, France. This study aimed to evaluate the usability of 2 successively developed prototypes of ARPEGE 2.0's electronic PROs module before launching a pilot study, owing to the novelty of the proposed data collection method for our setting and specific characteristics of the target population. A total of 2 sequential rounds of empirical, task-based usability evaluations were conducted, involving 8 research staff and then 7 people living with HIV. Evaluators provided written feedback during round 1 and oral feedback during round 2. Evaluators who completed the full set of tasks responded to the System Usability Scale (SUS). We assessed changes in SUS scores between rounds and concluded usability testing when SUS scores reached a ceiling effect, defining good usability a priori as a usability score of 70. Insights were generated regarding the visibility of system status and the match between the system and the real world that improved the module's usability. Research staff evaluators reported mean SUS scores of 65 (SD 18.87) and patient evaluators reported mean SUS scores of 85 (SD 5.4; P=.032). Software modifications, informed by successive rounds of usability testing, resulted in sufficient gains in usability to undertake piloting. Insights generated during evaluations prompted us to find the appropriate balance between optimal security and ease of use. ClinicalTrials.gov NCT03296202; https://clinicaltrials.gov/ct2/show/NCT03296202. RR2-10.2196/10.2196/resprot.9439.

Sections du résumé

BACKGROUND BACKGROUND
Patient-reported outcomes (PROs) can be of great value for both research and chronic disease management. We developed a new module of the ANRS CO3 Aquitaine cohort study's Web-based data capture and visualization solution (APPEGE 2.0) for the collection of electronic PROs among people living with HIV cared for in Nouvelle Aquitaine, France.
OBJECTIVE OBJECTIVE
This study aimed to evaluate the usability of 2 successively developed prototypes of ARPEGE 2.0's electronic PROs module before launching a pilot study, owing to the novelty of the proposed data collection method for our setting and specific characteristics of the target population.
METHODS METHODS
A total of 2 sequential rounds of empirical, task-based usability evaluations were conducted, involving 8 research staff and then 7 people living with HIV. Evaluators provided written feedback during round 1 and oral feedback during round 2. Evaluators who completed the full set of tasks responded to the System Usability Scale (SUS). We assessed changes in SUS scores between rounds and concluded usability testing when SUS scores reached a ceiling effect, defining good usability a priori as a usability score of 70.
RESULTS RESULTS
Insights were generated regarding the visibility of system status and the match between the system and the real world that improved the module's usability. Research staff evaluators reported mean SUS scores of 65 (SD 18.87) and patient evaluators reported mean SUS scores of 85 (SD 5.4; P=.032).
CONCLUSIONS CONCLUSIONS
Software modifications, informed by successive rounds of usability testing, resulted in sufficient gains in usability to undertake piloting. Insights generated during evaluations prompted us to find the appropriate balance between optimal security and ease of use.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT03296202; https://clinicaltrials.gov/ct2/show/NCT03296202.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
RR2-10.2196/10.2196/resprot.9439.

Identifiants

pubmed: 31850847
pii: v3i4e15013
doi: 10.2196/15013
pmc: PMC6939280
doi:

Banques de données

ClinicalTrials.gov
['NCT03296202']

Types de publication

Journal Article

Langues

eng

Pagination

e15013

Informations de copyright

©Diana Barger, Olivier Leleux, Valérie Conte, Vincent Sapparrart, Marie Gapillout, Isabelle Crespel, Marie Erramouspe, Sandrine Delveaux, Linda Wittkop, François Dabis, Fabrice Bonnet. Originally published in JMIR Formative Research (http://formative.jmir.org), 18.12.2019.

Références

Lancet HIV. 2019 Feb;6(2):e69-e70
pubmed: 30683626
Qual Life Res. 2012 Oct;21(8):1305-14
pubmed: 22048932
AIDS Behav. 2013 Oct;17(8):2781-91
pubmed: 23086427
Patient. 2017 Apr;10(2):187-202
pubmed: 27637488
BMC Med. 2016 Jun 22;14(1):94
pubmed: 27334606
Clin Infect Dis. 2012 Jan 1;54(1):141-7
pubmed: 22042879
Value Health. 2009 Jun;12(4):419-29
pubmed: 19900250
Curr HIV Res. 2007 Jan;5(1):109-18
pubmed: 17266562
Qual Life Res. 2007 Oct;16(8):1407-17
pubmed: 17668293
BMC Med. 2012 Jul 04;10:68
pubmed: 22762722
Lancet. 2013 Nov 2;382(9903):1525-33
pubmed: 24152939
JMIR Res Protoc. 2018 Jun 07;7(6):e147
pubmed: 29880467
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
AIDS Behav. 2012 Feb;16(2):452-60
pubmed: 21181253
Eur J Public Health. 2015 Aug;25(4):604-9
pubmed: 25624273
Lancet HIV. 2017 Aug;4(8):e349-e356
pubmed: 28501495
N Engl J Med. 2015 Aug 27;373(9):795-807
pubmed: 26192873
Patient. 2018 Dec;11(6):591-598
pubmed: 29968179
Alcohol Clin Exp Res. 2005 May;29(5):844-54
pubmed: 15897730
Soc Sci Med. 2005 Feb;60(4):833-43
pubmed: 15571900

Auteurs

Diana Barger (D)

University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, Team MORPH3EUS, UMR 1219, Bordeaux, France.

Olivier Leleux (O)

University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, Team MORPH3EUS, UMR 1219, Bordeaux, France.

Valérie Conte (V)

Centre de Recherche et Développement en Informatique Médicale, University of Bordeaux, Bordeaux, France.

Vincent Sapparrart (V)

Centre de Recherche et Développement en Informatique Médicale, University of Bordeaux, Bordeaux, France.

Marie Gapillout (M)

Centre de Recherche et Développement en Informatique Médicale, University of Bordeaux, Bordeaux, France.

Isabelle Crespel (I)

CHU de Bordeaux, COREVIH Nouvelle Aquitaine, Bordeaux, France.

Marie Erramouspe (M)

AIDES Nouvelle Aquitaine, Bordeaux, France.

Sandrine Delveaux (S)

CHU de Bordeaux, COREVIH Nouvelle Aquitaine, Bordeaux, France.

Linda Wittkop (L)

University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, Team MORPH3EUS, UMR 1219, Bordeaux, France.
CHU de Bordeaux, Service d'information médicale, Pôle de sante publique, Bordeaux, France.

François Dabis (F)

University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, Team MORPH3EUS, UMR 1219, Bordeaux, France.
CHU de Bordeaux, COREVIH Nouvelle Aquitaine, Bordeaux, France.

Fabrice Bonnet (F)

University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, Team MORPH3EUS, UMR 1219, Bordeaux, France.
CHU de Bordeaux, COREVIH Nouvelle Aquitaine, Bordeaux, France.
CHU de Bordeaux, Service de médecine interne et maladie infectieuses, Bordeaux, France.

Classifications MeSH